Cite
HARVARD Citation
Rathi, C. et al. (2021). Population pharmacokinetics of belantamab mafodotin, a BCMA‐targeting agent in patients with relapsed/refractory multiple myeloma. CPT: pharmacometrics & systems pharmacology. pp. 851-863. [Online].